Background: The 2020 European Society of Cardiology (ESC) guidelines recommend using
the 0/1-hour and 0/2-hour algorithms over the 0/3-hour algorithm as the first and second …

Copies: This document is available on the website of the American College of Cardiology
(www. acc. org). For copies of this document, please contact Elsevier Inc. Reprint …

Acute myocardial infarction (AMI) is a leading cause of mortality globally, highlighting the
need for timely and accurate diagnostic strategies. Cardiac troponin has been the biomarker …

Background: Although the 99th percentile is the recommended diagnostic threshold for
myocardial infarction, some guidelines also advocate the use of higher troponin thresholds …

Aims Patients with acute or chronic myocardial injury are frequently identified in the context
of suspected myocardial infarction (MI). We aimed to investigate their long-term follow-up …

The aim of this narrative review is to update the current knowledge on the differential choice
of circulating cardiac biomarkers in patients with prediabetes and established type 2 …

Background Over the past decade, intense collaboration between academic investigators
and the diagnostic industry have allowed the integration of high-sensitivity cardiac troponin …

Aims The role of biomarkers in predicting cardiovascular outcomes in high-risk individuals is
not well established. We aimed to investigate benefits of adding biomarkers to …

Background. Young patients with type 2 diabetes mellitus (DM) and acute myocardial
infarction (AMI) have high long‐term all‐cause and cardiovascular mortality rates. We aimed …

Introduction A rapid diagnosis of myocardial infarction (MI) is of utmost importance in order
to provide adequate therapy for patients that suffer from acute ischemic cardiac injury …